[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359292-105":59,"doc-detail-359292-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","phgdh-phosphorylation-mediated-by-wnk1-serves-as-a-dual-marker-of-metabolic-vulnerability-and-responsiveness-to-oxaliplatin-treatment","PHGDH phosphorylation mediated by WNK1 serves as a dual marker of metabolic vulnerability and responsiveness to oxaliplatin treatment","","Metabolic reprogramming drives cancer progression, yet how serine metabolism governs chemotherapeutic sensitivity in gastric cancer remains unclear. This study uses integrated metabolomics and 13C-labeled metabolic flux analysis to reveal dysregulated serine metabolism driven by increased PHGDH expression. WNK1 phosphorylates PHGDH at Ser349 and Ser371, boosting enzymatic activity and stability by blocking ubiquitin-mediated degradation. In mice, WNK1 loss reduces gastric tumor burden, serine abundance, and redox balance, while patient cohorts link elevated PHGDH activity and glutathione to poor oxaliplatin response.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/phgdh-phosphorylation-mediated-by-wnk1-serves-as-a-dual-marker-of-metabolic-vulnerability-and-responsiveness-to-oxaliplatin-treatment/359292/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/phgdh-phosphorylation-mediated-by-wnk1-serves-as-a-dual-marker-of-metabolic-vulnerability-and-responsiveness-to-oxaliplatin-treatment/359292.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does WNK1 affect PHGDH in gastric cancer?","Question",{"text":113,"@type":114},"WNK1 phosphorylates PHGDH at Ser349 and Ser371, enhancing PHGDH enzymatic activity and protein stability by preventing ubiquitin-mediated degradation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What evidence supports a connection between PHGDH activity and oxaliplatin response?",{"text":118,"@type":114},"Patient cohorts show that increased PHGDH activity and serine levels, along with higher glutathione abundance, are strongly associated with poor oxaliplatin responsiveness.",{"name":120,"@type":111,"acceptedAnswer":121},"What changes occur in WNK1 knockout mice regarding tumor growth and metabolism?",{"text":122,"@type":114},"WNK1 knockout mice exhibit significantly reduced gastric tumor burden, decreased serine levels, and disrupted redox balance.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},359292,1790167128,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","RESEARCH ARTICLE  \nCELL BIOLOGY  \n OPEN ACCESS  \nPHGDH phosphorylation mediated by WNK1 serves as a dual marker of metabolic vulnerability and responsiveness to oxaliplatin treatment  \nShaobo Fanga, b, 1, Guoguo Jinb,c,d,e, 1,2, Mingyang Yanb,f, Yanming Songb, Simin Zhaob,e,g , Chengjuan Zhangg, Yang Shaob,c,f, Kexin Zhaob,f, Meng Liub,f,  \nZhenwei Wangb,f, Xinyang Jiab,f, Qinxin Guob,f, Manman Guob,f, Meiyun Wanga, h,2 , Zhiping Guoc,d,2, and Zigang Dongb,e,f,2  Affiliations are included on p. 12.  \nEdited by Zhu Chen, Shanghai Jiao Tong University, Shanghai, China; received September 10, 2025; accepted February 12, 2026  \nMetabolic reprogramming is a fundamental hallmark of cancer progression. However, the oncogenic mechanisms underlying serine metabolism and its impact on chemotherapeutic sensitivity in gastric cancer (GC) remain poorly defned. Here, through integrated metabolomics and 13C-labeled metabolic fux analysis, we identify marked dysregulation of serine metabolism in GC, primarily driven by increased expression of phosphoglycerate dehydrogenase (PHGDH) . Mechanistically, we show that with no lysine kinase 1 (WNK1) phosphorylates PHGDH at Ser349 and Ser371, enhancing its enzymatic activity and protein stability by preventing ubiquitin-mediated degradation. In vivo, WNK1 knockout mice exhibit signifcantly reduced gastric tumor burden, accompanied by decreased serine levels and disrupted redox balance, supporting the protumorigenic role oftheWNK1–PHGDH axis. Clinically, enhanced PHGDH activity, elevated serine levels, and increased glutathione abundance are strongly associated with poor oxaliplatin response in GC patient cohorts, suggesting PHGDH as a potential predictive biomarker for chemotherapy resistance. Together, these fndings delineate aWNK1–PHGDH–driven serine metabolic reprogramming axis that promotes redox adaptation and chemoresistance in GC, highlighting its dual value as a mechanistic driver and a therapeutic vulnerability in cancer treatment.  \nserine metabolism | PHGDH | WNK1 | oxaliplatin treatment | therapeutic vulnerability  \nMetabolic reprogramming is a well-established hallmark of cancer, enabling tumor cells to survive and proliferate under hostile microenvironmental conditions such as hypoxia, nutrient deprivation, and oxidative stress ( 1, 2). Among various metabolic pathways, amino acid metabolism has emerged as a critical regulator of tumor growth, metastasis, immune evasion, and therapeutic resistance. Specifc amino acids—including asparagine and branched-chain amino acids—have been shown to infuence diverse oncogenic processes ranging from epigenetic modifcation to mTOR signaling activation (3, 4) . However, the clinical translation of these metabolic insights remains limited, and the therapeutic potential of targeting amino acid metabolism in cancer treatment is far from fully realized.  \nAmong nonessential amino acids, serine plays a central role in several fundamental metabolic processes (5–7). Serine serves as a precursor for cysteine, which is subsequently utilized in the synthesis of glutathione (GSH) . GSH is a major endogenous antioxidant that plays a critical role in detoxifying reactive oxygen species (ROS) and maintaining cellular redox balance. Enhanced GSH production is a common adaptive response by cancer cells to counteract oxidative stress and promote survival (8) . Several studies have demonstrated that restricting serine uptake or inhibiting its biosynthesis signifcantly suppresses tumor growth and improves survival in preclinical models (9–11) . However, the specifc mechanisms by which serine metabolism contributes to chemotherapy resistance and regulated cell death remain poorly understood—particularly in gastric cancer. Phosphoglycerate dehydrogenase (PHGDH), the rate-limiting enzyme in the de novo serine biosynthesis pathway, plays a key role in sustaining the production of metabolic intermediates essential for rapid cancer cell proliferation ( 12, 13) . Although the ","cbCairBmdByybp5O","https://ap.wps.com/l/cbCairBmdByybp5O","pdf",7442530,12,"English","# Significance\n# Author contributions\n# Competing interest and publication notes","[{\"question\":\"How does WNK1 affect PHGDH in gastric cancer?\",\"answer\":\"WNK1 phosphorylates PHGDH at Ser349 and Ser371, enhancing PHGDH enzymatic activity and protein stability by preventing ubiquitin-mediated degradation.\"},{\"question\":\"What evidence supports a connection between PHGDH activity and oxaliplatin response?\",\"answer\":\"Patient cohorts show that increased PHGDH activity and serine levels, along with higher glutathione abundance, are strongly associated with poor oxaliplatin responsiveness.\"},{\"question\":\"What changes occur in WNK1 knockout mice regarding tumor growth and metabolism?\",\"answer\":\"WNK1 knockout mice exhibit significantly reduced gastric tumor burden, decreased serine levels, and disrupted redox balance.\"}]","PHGDH phosphorylation mediated by WNK1 serves as a dual marker of metabolic vulnerability and responsiveness to oxaliplatin treatment | PDF",1790136611,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d269d4b57bd57cd35e7d3c36440a8127.webp",983,1316,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a53269c1b360adbde0f9a0164bcfd86.webp",982,1315,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6ec922c7ce8805f114faf90b2a4249b.webp",981,1313,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4f9148d03c8f73e07dba758d19b8aa7.webp",980,1312]